Cite
HARVARD Citation
Shah, A. et al. (2020). Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy. Journal of medical economics. pp. 330-346. [Online].